Tirzepatide is a synthetic peptide and a novel dual agonist of both the GLP-1 (glucagon-like peptide-1) and GIP (gastric inhibitory polypeptide) receptors. Initially developed to treat type 2 diabetes, it has also shown significant promise in promoting weight loss and improving metabolic health. By mimicking these natural gut hormones, tirzepatide helps regulate blood sugar levels, reduce appetite, and enhance insulin sensitivity.
